Carter GL, Lewin TJ, Gianacas L, Clover K, Adams C Caregiver satisfaction with out-patient oncology services: utility of the FAMCARE instrument and development of the FAMCARE-6. Support Care Cancer. 2011 Apr;19(4):565-72. doi: 10.1007/s00520-010-0858-1. Epub 2010 Mar 28.
Cheifetz O, Packham TL, Macdermid JC Rasch analysis of the Edmonton Symptom Assessment System and research implications. Curr Oncol. 2014 Apr;21(2):e186-94. doi: 10.3747/co.21.1735.
Colon M Hospice and Latinos: a review of the literature. J Soc Work End Life Palliat Care. 2005;1(2):27-43. Review.
Daugherty CK, Hlubocky FJ What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosure. J Clin Oncol. 2008 Dec 20;26(36):5988-93. doi: 10.1200/JCO.2008.17.2221. Epub 2008 Nov 24.
de Kock I, Mirhosseini M, Lau F, Thai V, Downing M, Quan H, Lesperance M, Yang J Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. J Palliat Care. 2013 Autumn;29(3):163-9.
Degenholtz HB, Thomas SB, Miller MJ Race and the intensive care unit: disparities and preferences for end-of-life care. Crit Care Med. 2003 May;31(5 Suppl):S373-8. Review.
El-Jawahri A, Greer JA, Temel JS Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol. 2011 May-Jun;9(3):87-94. Review.
Enguidanos S, Housen P, Goldstein R, Vesper E, Allen J, Braun W Physician and nurse perceptions of a new inpatient palliative care consultation project: implications for education and training. J Palliat Med. 2009 Dec;12(12):1137-42. doi: 10.1089/jpm.2009.0131.
Glare PA, Semple D, Stabler SM, Saltz LB Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria. J Oncol Pract. 2011 Nov;7(6):366-70. doi: 10.1200/JOP.2011.000367.
Meier DE, Beresford L Outpatient clinics are a new frontier for palliative care. J Palliat Med. 2008 Jul;11(6):823-8. doi: 10.1089/jpm.2008.9886.
Milne D, Aranda S, Jefford M, Schofield P Development and validation of a measurement tool to assess perceptions of palliative care. Psychooncology. 2013 Apr;22(4):940-6. doi: 10.1002/pon.3071. Epub 2012 Mar 27.
Morrison RS, Augustin R, Souvanna P, Meier DE America's care of serious illness: a state-by-state report card on access to palliative care in our nation's hospitals. J Palliat Med. 2011 Oct;14(10):1094-6. doi: 10.1089/jpm.2011.9634. Epub 2011 Sep 16.
O'Mahony S, McHenry J, Snow D, Cassin C, Schumacher D, Selwyn PA A review of barriers to utilization of the medicare hospice benefits in urban populations and strategies for enhanced access. J Urban Health. 2008 Mar;85(2):281-90. doi: 10.1007/s11524-008-9258-y. Review.
Oechsle K, Goerth K, Bokemeyer C, Mehnert A Anxiety and depression in caregivers of terminally ill cancer patients: impact on their perspective of the patients' symptom burden. J Palliat Med. 2013 Sep;16(9):1095-101. doi: 10.1089/jpm.2013.0038. Epub 2013 Aug 3.
Pantilat SZ, Kerr KM, Billings JA, Bruno KA, O'Riordan DL Palliative care services in California hospitals: program prevalence and hospital characteristics. J Pain Symptom Manage. 2012 Jan;43(1):39-46. doi: 10.1016/j.jpainsymman.2011.03.021. Epub 2011 Jul 30.
Peppercorn, J M., Smith, T. J., Helft, P. R., Debono, D. J., Berry, S. R., Wollins, D. S., (2011). American Society of Clinical Oncology. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29(6), 755-760. doi:10.1200/JCO.2010.33.1744
Quill TE, Abernethy AP Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med. 2013 Mar 28;368(13):1173-5. doi: 10.1056/NEJMp1215620. Epub 2013 Mar 6.
Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med. 2004 Jan 12;164(1):83-91.
Ramey SJ, Chin SH Disparity in hospice utilization by African American patients with cancer. Am J Hosp Palliat Care. 2012 Aug;29(5):346-54. doi: 10.1177/1049909111423804. Epub 2011 Oct 23. Review.
Rogers M, Todd C Information exchange in oncology outpatient clinics: source, valence and uncertainty. Psychooncology. 2002 Jul-Aug;11(4):336-45.
Von Roenn JH, Temel J The integration of palliative care and oncology: the evidence. Oncology (Williston Park). 2011 Nov 30;25(13):1258-60, 1262, 1264-5. Review.
Walshe C, Todd C, Caress A, Chew-Graham C Patterns of access to community palliative care services: a literature review. J Pain Symptom Manage. 2009 May;37(5):884-912. doi: 10.1016/j.jpainsymman.2008.05.004. Epub 2008 Dec 21. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.